• Brendan Collins, Chris Kypridemos, Jonathan Pearson-Stuttard, Yue Huang, Piotr Bandosz, Parke Wilde, Rogan Kersh, Simon Capewell, Dariush Mozaffarian, Laurie P Whitsel, Renata Micha, Martin O'Flaherty, and Food-PRICE Investigators.
• University of Liverpool.
• Milbank Q. 2019 Sep 1; 97 (3): 858-880.

AbstractPolicy Points The World Health Organization has recommended sodium reduction as a "best buy" to prevent cardiovascular disease (CVD). Despite this, Congress has temporarily blocked the US Food and Drug Administration (FDA) from implementing voluntary industry targets for sodium reduction in processed foods, the implementation of which could cost the industry around $16 billion over 10 years. We modeled the health and economic impact of meeting the two-year and ten-year FDA targets, from the perspective of people working in the food system itself, over 20 years, from 2017 to 2036. Benefits of implementing the FDA voluntary sodium targets extend to food companies and food system workers, and the value of CVD-related health gains and cost savings are together greater than the government and industry costs of reformulation.© 2019 The Authors The Milbank Quarterly published by Wiley Periodicals, Inc. on behalf of The Millbank Memorial Fund.

16 keywords...

hide…